Following the implantation of ovarian cancer cells, the resulting inflammation causes the release of cytokines such as interleukin (IL)-1, -8, and -6 by peritoneal cells and their associated stromal and immune cells, which drive tumor angiogenesis and ascites formation by enhancing tumor cell VEGF secretion [37]. The gene discussed is VEGFA; the disease is neoplasm.